Abstract:Abstract Background Inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC) are closely associated pathological entities that, when present in combination, create a phenotypically different disease, referred to as PSC-IBD. The occurrence of PSC complicating IBD seems to vary depending on the studied population. The aim of this study was to describe the clinical profile of patients with PSC-IBD in reference centers in Brazil. Methods Descriptive cross-sectional study in 7 tertiary centers. Patients with PSC and IBD were identified. Data were collected from patients' charts. The following variables were studied: age, age at diagnosis of IBD and PSC, type of IBD, Montreal classification, medications used, occurrence of colorectal cancer and dysplasia, colectomy and liver complications. The study was approved by the ethics and research committee. Results Ninety-three patients were included. The mean age of the patients was 43,8 years (range 17 to 73). 63 patients were male (67.7%). UC was more frequent 74.2% (N=69). The mean age at diagnosis of IBD and PSC was 31.4 years (range 6 to 67) and 35.6 years (range 8 to 72), respectively. The diagnosis of PSC preceded that of IBD in only 15 (16.1%) cases. Among patients with UC, the majority (61/69) had extensive colitis (88.4%), and 47.8% (33/69) had already used at least one biological therapy. Only 9 (13%) patients with UC required colectomy. Regarding CD, colon involvement occurred in 21 (87.5%) patients and 20 (83.3%) needed to use at least one biologic. Just 3 CD patients (12.5%) had isolated disease in the small intestine. In our study, liver cirrhosis occurred in 20 (21,5%) cases of the studied population, and 13 (14%) patients required liver transplantation. Fourteen (15,1%) IBD patients had dysplasia or colorectal cancer (CRC). Use of biological therapy was more frequent in patients with CD than in those with UC (83.3% vs 47.8%; p=0.002). There was a trend towards a higher occurrence of CRC in the UC population (p=0.08). Conclusion In our studied PSC-IBD population, UC was more common than CD. Furthermore, we observed that in this subgroup of IBD with PSC, UC presented a more severe phenotype, with a superior occurrence of extensive colitis and need for biological therapy. In CD, most patients have colonic involvement. Interestingly, we observed a greater need to use at least one biologic in CD patients (p=0.002), as well as the need to use multiple biologics compared to UC patients (p=0.009). Additionally, there was a trend towards greater occurrence of CRC in UC patients. The rates of occurrence of dysplasia and liver cirrhosis in our casuistic emphasize the demand for more intensive follow-up in patients with IBD and PSC.

A Patient with Primary Biliary Cirrhosis and Ulcerative Colitis with Progression to Primary Sclerosing Cholangitis and Colorectal Cancer: A Case Report

Clinical Analysis of Primary Biliary Cirrhosis: a Report of 31 Cases

Primary Biliary Cirrhosis and Ulcerative Colitis: A Case Report and Review of Literature

P812 Inflammatory bowel disease and hepatopathies: Beyond primary sclerosing cholangitis

Elevated Liver Fibrosis Progression in Isolated PSC Patients and Increased Malignancy Risk in a PSC-IBD Cohort: A Retrospective Study

Primary Sclerosing Cholangitis and Crohn's Disease: A Rare Association

Budd-Chiari Syndrome Complicated with Hepatocellular Carcinoma: a Clinical Analysis of 36 Cases

Successful Treatment of Colorectal Liver Metastasis Harboring Intrahepatic Cholangiocarcinoma

P373 Primary sclerosing cholangitis associated with inflammatory bowel disease: clinical characteristics of patients from reference centers in Brazil

The primary sclerosing cholangitis and ulcerative colitis colonic mucosa defined through paired microbial and single-cell RNA sequencing

Risk of colorectal cancer in patients with primary sclerosing cholangitis and concomitant inflammatory bowel disease compared with primary sclerosing cholangitis only

Primary sclerosing cholangitis - an insidious enemy of the liver - case report

Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis

Clinical Characteristics of Systemic Sclerosis Complicated with Primary Biliary Cholangitis and Portal Hypertension:Analysis of 12 Cases

IDDF2022-ABS-0112 Clinical Features in Primary Biliary Cholangitis: a Retrospective Analysis of 52 Cases

Clinically significant portal hypertension in patients with primary biliary cholangitis: Clinicopathological features and prognostic value

Clinical and Pathology Analysis of Patients with Primary Biliary Cirrhosis

Clinical Characteristics of Primary Biliary Cirrhosis: a Retrospective Analysis of 101 Cases

P119 Single-cell RNA sequencing in Inflammatory Bowel Disease in patients with Primary Sclerosing Cholangitis: a distinct form of colitis

Clinical Study of 25 Primary Biliary Cirrhosis Cases

A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways